Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CBER
Biotech
FDA's Peter Marks doesn't plan to retire soon—Chutes & Ladders
Peter Marks doesn't have any plans to leave the FDA—yet. Anthony Fauci's replacement has been named. Jamie Rubin takes CFO role at Boundless.
Max Bayer
,
Gabrielle Masson
,
Annalee Armstrong
Aug 4, 2023 9:30am
FDA's Marks overrules staff drug reviewers 'with trepidation'
Jul 27, 2023 3:05pm
New federal biotech commission taps 12 members—Chutes & Ladders
Feb 3, 2023 10:20am
European orgs launch moonshot of their own for rare diseases
Dec 7, 2022 6:01pm
Moderna CFO Gomez departs after just one day—Chutes & Ladders
May 13, 2022 9:30am
Operation Warp Speed 2.0? Not without more staff, says Marks
May 11, 2022 9:15am